Breast cancer survivorship care beyond local and systemic therapy

Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 68, 394, 10.3322/caac.21492 Allemani, 2018, Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries, The Lancet, 391, 1023, 10.1016/S0140-6736(17)33326-3 Ginsburg, 2017, The global burden of women’s cancers: a grand challenge in global health, The Lancet, 389, 847, 10.1016/S0140-6736(16)31392-7 Muss, 2005, Adjuvant chemotherapy in older and younger women with lymph node–positive breast cancer, JAMA, 293, 1073, 10.1001/jama.293.9.1073 Masuda, 2017, Adjuvant capecitabine for breast cancer after preoperative chemotherapy, N Engl J Med, 376, 2147, 10.1056/NEJMoa1612645 Sparano, 2018, Adjuvant chemotherapy Guided by a 21-gene expression assay in breast cancer, N Engl J Med, 379, 111, 10.1056/NEJMoa1804710 von Minckwitz, 2019, Trastuzumab emtansine for residual invasive HER2-positive breast cancer, N Engl J Med, 380, 617, 10.1056/NEJMoa1814017 Schnipper, 2015, American society of clinical oncology statement: a conceptual framework to assess the value of cancer treatment options, J Clin Oncol, 33, 2563, 10.1200/JCO.2015.61.6706 Schnipper, 2009, ASCO addresses the rising cost of cancer care, J Oncol Pract, 5, 214, 10.1200/JOP.0941504 Tao, 2015, Long term side effects of adjuvant chemotherapy in patients with early breast cancer, The Breast, 24, S149, 10.1016/j.breast.2015.07.035 Ruddy, 2014, Prospective study of fertility concerns and preservation strategies in young women with breast cancer, J Clin Oncol, 32, 1151, 10.1200/JCO.2013.52.8877 Lambertini, 2017, Controversies about fertility and pregnancy issues in young breast cancer patients: current state of the art, Curr Opin Oncol, 29, 243, 10.1097/CCO.0000000000000380 Dieci, 2019, Patterns of fertility preservation and pregnancy outcome after breast cancer at a large comprehensive cancer center, J Womens Health, 28, 544, 10.1089/jwh.2018.6986 Oktay, 2018, Fertility preservation in patients with cancer: ASCO clinical practice guideline update, J Clin Oncol, 36, 1994, 10.1200/JCO.2018.78.1914 Smith KL, Gracia C, Sokalska A, Moore H. Advances in fertility preservation for young women with cancer. Am Soc Clin Oncol Educ Book 2018;:27–37. Lambertini, 2018, The BCY3/BCC 2017 survey on physicians’ knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients, The Breast, 42, 41, 10.1016/j.breast.2018.08.099 Schoch, 2004, Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML, Leukemia, 18, 120, 10.1038/sj.leu.2403187 Smith, 2003, Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the national surgical adjuvant breast and bowel project experience, J Clin Oncol, 21, 1195, 10.1200/JCO.2003.03.114 Wolff, 2015, Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience, J Clin Oncol, 33, 340, 10.1200/JCO.2013.54.6119 Muss, 2007, Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the cancer and leukemia group B experience, J Clin Oncol, 25, 3699, 10.1200/JCO.2007.10.9710 Patt, 2007, Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding risk, J Clin Oncol, 25, 3871, 10.1200/JCO.2007.12.0832 Bray, 2017, Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation, Obes Rev, 18, 715, 10.1111/obr.12551 Afshin, 2017, Health effects of overweight and obesity in 195 countries over 25 years, N Engl J Med, 377, 13, 10.1056/NEJMoa1614362 Flegal, 2016, Trends in obesity among adults in the United States, 2005 to 2014, JAMA, 315, 2284, 10.1001/jama.2016.6458 Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity among adults and youth: United States, 2015-2016. NCHS Data Brief 2017;:1–8. 2012 Rojas, 2018, Body mass index (BMI), postoperative appearance satisfaction, and sexual function in breast cancer survivorship, J Cancer Surviv Res Pract, 12, 127, 10.1007/s11764-017-0651-y Imayama, 2013, Weight, inflammation, cancer-related symptoms and health related quality of life among breast cancer survivors, Breast Cancer Res Treat, 140, 159, 10.1007/s10549-013-2594-y Mustafa, 2017, Long-term peripheral neuropathy symptoms in breast cancer survivors, Breast Cancer Res Treat, 166, 519, 10.1007/s10549-017-4437-8 Greenlee, 2016, BMI, lifestyle factors and taxane-induced neuropathy in breast cancer patients: the pathways study, J Natl Cancer Inst, 109, 1 Bao, 2016, Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: Prevalence, risk factors, and fall risk, Breast Cancer Res Treat, 159, 327, 10.1007/s10549-016-3939-0 Ridner, 2011, Body mass index and breast cancer treatment-related lymphedema, Support Care Cancer, 19, 853, 10.1007/s00520-011-1089-9 Schmidt, 2018, Determinants of physical, affective, and cognitive fatigue during breast cancer therapy and 12 months follow-up, Int J Cancer, 142, 1148, 10.1002/ijc.31138 Herath, 2016, Impact of obesity and exercise on chemotherapy-related fatigue, Support Care Cancer, 24, 4257, 10.1007/s00520-016-3257-4 Lauby-Secretan, 2016, Body fatness and cancer – viewpoint of the IARC Working Group, N Engl J Med, 375, 794, 10.1056/NEJMsr1606602 Gross, 2015, Weight change in breast cancer survivors compared to cancer-free women: a prospective study in women at familial risk of breast cancer, Cancer Epidemiol Prev Biomark, 24, 1262, 10.1158/1055-9965.EPI-15-0212 Sheng, 2018, Obese breast cancer patients and survivors: management considerations, Oncology, 32, 410 Michaud, 2017, Cost effectiveness and return on investment of a scalable community weight loss intervention, Prev Med, 105, 295, 10.1016/j.ypmed.2017.10.011 Dieli-Conwright CM, Courneya KS, Demark-Wahnefried W, et al. Effects of aerobic and resistance exercise on metabolic syndrome, sarcopenic obesity, and circulating biomarkers in overweight or obese survivors of breast cancer: a randomized controlled trial. J Clin Oncol 2018;JCO2017757526. Bail, 2018, A home-based mentored vegetable gardening intervention demonstrates feasibility and improvements in physical activity and performance among breast cancer survivors, Cancer, 0, 1 Brown, 2018, Randomized trial of a clinic-based weight loss intervention in cancer survivors, J Cancer Surviv, 12, 186, 10.1007/s11764-017-0657-5 Ligibel, 2016, Randomized trial of a physical activity intervention in women with metastatic breast cancer, Cancer, 122, 1169, 10.1002/cncr.29899 Ligibel JA, Barry WT, Alfano C, et al. Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design. NPJ Breast Cancer [Internet] 2017 [cited 2018 Jan 7];3. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608692/. Howell, 2014, Sleep disturbance in adults with cancer: a systematic review of evidence for best practices in assessment and management for clinical practice, Ann Oncol, 25, 791, 10.1093/annonc/mdt506 Zachariae, 2018, Internet-delivered cognitive-behavioral therapy for insomnia in breast cancer survivors: a randomized controlled trial, J Natl Cancer Inst, 110, 880, 10.1093/jnci/djx293 Zhou, 2017, A pilot trial of brief group cognitive-behavioral treatment for insomnia in an adult cancer survivorship program, Psychooncology, 26, 843, 10.1002/pon.4096 Irwin, 2017, J Clin Oncol, 3535, 2656, 10.1200/JCO.2016.71.0285 Kanani, 2016, The association of mood disorders with breast cancer survival: an investigation of linked cancer registration and hospital admission data for South East England, Psychooncology, 25, 19, 10.1002/pon.4037 Dalton, 2018, Impact of schizophrenia and related disorders on mortality from breast cancer: A population-based cohort study in Denmark, 1995-2011, Breast, 40, 170, 10.1016/j.breast.2018.06.002 Syrowatka, 2018, Ability to predict new-onset psychological distress using routinely collected health data: a population-based cohort study of women diagnosed with breast cancer, J Natl Compr Canc Netw, 16, 1065, 10.6004/jnccn.2018.7038 Ghizzani, 2018, The sex life of women surviving breast cancer, Gynecol Endocrinol, 34, 821, 10.1080/09513590.2018.1467401 Cornell, 2017, Trends in sexual function after breast cancer surgery, Ann Surg Oncol, 24, 2526, 10.1245/s10434-017-5894-3 Kaur, 2018, Survivorship issues as determinants of quality of life after breast cancer treatment: Report from a limited resource setting, Breast, 41, 120, 10.1016/j.breast.2018.07.003 Reese, 2019, A randomized pilot trial of a couple-based intervention addressing sexual concerns for breast cancer survivors, J Psychosoc Oncol, 37, 242, 10.1080/07347332.2018.1510869 Sherman, 2018, Reducing body image-related distress in women with breast cancer using a structured online writing exercise: results from the my changed body randomized controlled trial, J Clin Oncol, 36, 1930, 10.1200/JCO.2017.76.3318 Hummel, 2017, Efficacy of internet-based cognitive behavioral therapy in improving sexual functioning of breast cancer survivors: results of a randomized controlled trial, J Clin Oncol, 35, 1328, 10.1200/JCO.2016.69.6021 Burstein, 2014, Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update, J Clin Oncol, 32, 2255, 10.1200/JCO.2013.54.2258 Henry, 2012, Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer, J Clin Oncol, 30, 936, 10.1200/JCO.2011.38.0261 Goss, 2003, A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer, N Engl J Med, 349, 1793, 10.1056/NEJMoa032312 Thurlimann, 2005, A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer, N Engl J Med, 353, 2747, 10.1056/NEJMoa052258 Partridge, 2008, Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer, J Clin Oncol, 26, 556, 10.1200/JCO.2007.11.5451 Chlebowski, 2009, Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer, Breast, 18, S1, 10.1016/S0960-9776(09)70002-5 Buzdar, 2006, Arimidex, tamoxifen, alone or in combination trialists’ group comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial, Lancet Oncol, 7, 633, 10.1016/S1470-2045(06)70767-7 Crew, 2007, Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer, J Clin Oncol, 25, 3877, 10.1200/JCO.2007.10.7573 Castel, 2013, Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort, Cancer, 119, 2375, 10.1002/cncr.28016 Mao, 2009, Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors, Cancer, 115, 3631, 10.1002/cncr.24419 Aiello Bowles, 2012, Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer, J Oncol Pract, 8, e149, 10.1200/JOP.2012.000543 Gaillard, 2011, Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management, Breast Cancer Res, 13, 205, 10.1186/bcr2818 Din, 2010, Aromatase inhibitor-induced arthralgia in early breast cancer: what do we know and how can we find out more?, Breast Cancer Res Treat, 120, 525, 10.1007/s10549-010-0757-7 Niravath, 2013, Aromatase inhibitor-induced arthralgia: a review, Ann Oncol, 24, 1443, 10.1093/annonc/mdt037 Henry, 2017, Randomized, multicenter, placebo-controlled clinical trial of duloxetine versus placebo for aromatase inhibitor–associated arthralgias in early-stage breast cancer: SWOG S1202, J Clin Oncol, 36, 326, 10.1200/JCO.2017.74.6651 Chen, 2017, Effect of acupuncture on aromatase inhibitor-induced arthralgia in patients with breast cancer: A meta-analysis of randomized controlled trials, The Breast, 33, 132, 10.1016/j.breast.2017.03.015 Hershman, 2015, Randomized multicenter placebo-controlled trial of omega-3 fatty acids for the control of aromatase inhibitor–induced musculoskeletal pain: SWOG S0927, J Clin Oncol, 33, 1910, 10.1200/JCO.2014.59.5595 Nyrop, 2017, Randomized controlled trial of a home-based walking program to reduce moderate to severe aromatase inhibitor-associated arthralgia in breast cancer survivors, The Oncologist, 22, 1, 10.1634/theoncologist.2017-0174 Kirshner, 2018, NOLAN: a randomized, phase 2 study to estimate the effect of prophylactic naproxen or loratadine vs no prophylactic treatment on bone pain in patients with early-stage breast cancer receiving chemotherapy and pegfilgrastim, Support Care Cancer, 26, 1323, 10.1007/s00520-017-3959-2 Runowicz, 2016, American cancer society/american society of clinical oncology breast cancer survivorship care guideline, J Clin Oncol, 34, 611, 10.1200/JCO.2015.64.3809 Ramin, 2018, Evaluation of osteopenia and osteoporosis in younger breast cancer survivors compared with cancer-free women: a prospective cohort study, Breast Cancer Res, 20, 134, 10.1186/s13058-018-1061-4 Greenlee, 2016, Association between complementary and alternative medicine use and breast cancer chemotherapy initiation: the breast cancer quality of care (BQUAL) study, JAMA Oncol, 2, 1170, 10.1001/jamaoncol.2016.0685 Matsuno, 2012, Complementary and alternative medicine use and breast cancer prognosis: a pooled analysis of four population-based studies of breast cancer survivors, J Womens Health, 21, 1252, 10.1089/jwh.2012.3698 Greenlee, 2014, Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer, JNCI Monogr, 2014, 346, 10.1093/jncimonographs/lgu041 Lyman, 2018, Integrative therapies during and after breast cancer treatment: ASCO Endorsement of the SIO clinical practice guideline, J Clin Oncol, 36, 2647, 10.1200/JCO.2018.79.2721 Chavez-MacGregor, 2016, Delayed initiation of adjuvant chemotherapy among patients with breast cancer, JAMA Oncol, 2, 322, 10.1001/jamaoncol.2015.3856 Citrin, 2012, Beliefs and perceptions of women with newly diagnosed breast cancer who refused conventional treatment in favor of alternative therapies, The Oncologist, 17, 607, 10.1634/theoncologist.2011-0468 Reeder-Hayes, 2017, Breast cancer disparities at home and abroad: a review of the challenges and opportunities for system-level change, Clin Cancer Res, 23, 2655, 10.1158/1078-0432.CCR-16-2630 Anderson, 2007, Guidelines for improving breast health care in limited resource countries: the breast health global initiative, J Natl Compr Canc Netw, 5, 348, 10.6004/jnccn.2007.0031 Churilla, 2017, Disparities in the local management of breast cancer in the us according to health insurance status, Breast J, 23, 169, 10.1111/tbj.12705 Shih, 2017, Association between quality of care for breast cancer and health insurance exchange coverage: an analysis of use of radiation therapy after breast-conserving surgery, JAMA Oncol, 3, 1425, 10.1001/jamaoncol.2017.1287 Kehl, 2017, Access to accredited cancer hospitals within federal exchange plans under the affordable care act, J Clin Oncol, 35, 645, 10.1200/JCO.2016.69.9835 Gross, 2018, BRCA1 and BRCA2 testing in medically underserved medicare beneficiaries with breast or ovarian cancer, JAMA, 320, 597, 10.1001/jama.2018.8258 Giordano, 2016, Estimating regimen-specific costs of chemotherapy for breast cancer: Observational cohort study, Cancer, 122, 3447, 10.1002/cncr.30274 Ross M. What’s In A Word? The Evolution Of Effectiveness In Health Care [Internet]. Health Aff. (Millwood). [cited 2019 Feb 23];Available from: https://www.healthaffairs.org/do/10.1377/hblog20160726.055946/full/. Smith BD, Jiang J, Shih Y-C, et al. Cost and complications of local therapies for early-stage breast cancer. JNCI J Natl Cancer Inst [Internet] 2017 [cited 2018 Sep 17];109. Available from: https://academic.oup.com/jnci/article/109/1/djw178/2905640. Kim, 2018, Association between financial burden and adjuvant hormonal therapy adherence and persistent use for privately insured women aged 18-64 years in BCBS of Texas, Breast Cancer Res Treat, 169, 573, 10.1007/s10549-018-4704-3 Farias, 2016, Association between out-of-pocket costs, race/ethnicity, and adjuvant endocrine therapy adherence among medicare patients with breast cancer, J Clin Oncol, 35, 86, 10.1200/JCO.2016.68.2807 Biggers, 2016, Medicare D subsidies and racial disparities in persistence and adherence with hormonal therapy, J Clin Oncol, 34, 4398, 10.1200/JCO.2016.67.3350 Klaassen, 2018, A novel patient decision aid for aftercare in breast cancer patients: A promising tool to reduce costs by individualizing aftercare, The Breast, 41, 144, 10.1016/j.breast.2018.06.015 Schapira, 2019, The impact of a risk-based breast cancer screening decision aid on initiation of mammography among younger women: report of a randomized trial, MDM Policy Pract, 4 Blinder, 2012, Return to work in low-income Latina and non-Latina white breast cancer survivors: A 3-year longitudinal study, Cancer, 118, 1664, 10.1002/cncr.26478 Fantoni, 2010, factors related to return to work by women with breast cancer in Northern France, J Occup Rehabil, 20, 49, 10.1007/s10926-009-9215-y Landeiro LCG, Gagliato DM, Fêde AB, et al. Return to work after breast cancer diagnosis: An observational prospective study in brazil. Cancer [Internet] 2018 [cited 2018 Oct 23];0. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.31735. Hamood, 2019, Work transitions in breast cancer survivors and effects on quality of life, J Occup Rehabil, 29, 336, 10.1007/s10926-018-9789-3 Luis, 2018, Symptom burden and employment status in breast cancer (BC) survivors, J Clin Oncol, 36, 10073, 10.1200/JCO.2018.36.15_suppl.10073 Bristol-Myers Squibb. Cancer in the workplace [Internet]. Cancer Care. [cited 2019 Feb 25];Available from: http://cancersurvivorship.eiu.com/briefing-paper/ Cardoso, 2018, Global analysis of advanced/metastatic breast cancer: decade report (2005–2015), The Breast, 39, 131, 10.1016/j.breast.2018.03.002 The Editorial Board. Opinion|It’s Time for Pharmaceutical Companies to Have Their Tobacco Moment [Internet]. N. Y. Times. 2019 [cited 2019 Feb 25];Available from: https://www.nytimes.com/2019/02/24/opinion/drug-prices-congress.html. Sorensen, 2012, Incidence-based cost-of-illness model for metastatic breast cancer in the United States, Int J Technol Assess Health Care, 28, 12, 10.1017/S026646231100064X Corneliussen-James, 2011, International survey identifies key support and lifestyle needs of metastatic breast cancer (MBC) patients, The Breast, 20, S53, 10.1016/j.breast.2011.08.120 Altice CK, Banegas MP, Tucker-Seeley RD, Yabroff KR. Financial hardships experienced by cancer survivors: a systematic review. JNCI J Natl Cancer Inst [Internet] 2017 [cited 2018 Nov 20];109. Available from: https://academic.oup.com/jnci/article/109/2/djw205/2905657. Banegas, 2016, For working-age cancer survivors, medical debt and bankruptcy create financial hardships, Health Aff (Millwood), 35, 54, 10.1377/hlthaff.2015.0830 Zafar, 2013, The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient’s experience, The Oncologist, 18, 381, 10.1634/theoncologist.2012-0279 Dean, 2018, Consumer credit as a novel marker for economic burden and health after cancer in a diverse population of breast cancer survivors in the USA, J Cancer Surviv, 12, 306, 10.1007/s11764-017-0669-1 Souza, 2017, Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the comprehensive score for financial toxicity (COST), Cancer, 123, 476, 10.1002/cncr.30369 Zafar SY. Financial toxicity of cancer care: it’s time to intervene. JNCI J Natl Cancer Inst [Internet] 2016 [cited 2018 Nov 20];108. Available from: https://academic.oup.com/jnci/article/108/5/djv370/2412415. Kale, 2016, Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors, Cancer, 122, 283, 10.1002/cncr.29808 Ramsey, 2013, Washington state cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis, Health Aff (Millwood), 32, 1143, 10.1377/hlthaff.2012.1263 Ramsey, 2016, Financial insolvency as a risk factor for early mortality among patients with cancer, J Clin Oncol, 34, 980, 10.1200/JCO.2015.64.6620 Williams, 2018, Impact of guideline-discordant treatment on cost and health care utilization in older adults with early-stage breast cancer, The Oncologist, 23, 1 Rocque, 2018, Impact of Nonconcordance with NCCN guidelines on resource utilization, cost, and mortality in De Novo metastatic breast cancer, J Natl Compr Canc Netw, 16, 1084, 10.6004/jnccn.2018.7036 Carrera, 2018, The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment, CA Cancer J Clin, 68, 153, 10.3322/caac.21443 Sledge GW. Patients and physicians in the era of modern cancer care. JAMA [Internet] 2019 [cited 2019 Feb 23]; Available from: https://jamanetwork.com/journals/jama/fullarticle/2725529